ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

Outcomes of Staphylococcus aureus Bacteremia in Patients with Chronic Kidney Disease versus without Chronic Kidney Disease

Shinhye Cheon, Jungok Kim, Kyung Mok Sohn and Yeon-Sook Kim

Objectives: S. aureus bacteremia (SAB) is a leading cause of infection in patients with chronic kidney disease (CKD). Clinical outcomes associated with SAB in patients with CKD and with non-CKD were compared.

Materials and methods: Laboratory and clinical data from patients who were hospitalized with SAB in a tertiary care hospital were reviewed. Linear regression was used to identify independent predictors of 7-day, 30-day, and 90- day mortality.

Results and discussion: A total of 79 patients with CKD and 92 patients without CKD were enrolled from Mar 2014 to Dec 2016. Seven-day and 90-day mortality were increased in patients with CKD compared to patients with non-CKD (7-day mortality, 19% vs. 8.7%, p=0.011; 30-day mortality, 30.4% vs. 23.9%, p=0.058; 90-day mortality, 38.0% vs. 26.1%, p=0.002). Difference of Pitt bacteremia score and persistent bacteremia longer than 7 days among both groups was not statistically significant. High SOFA (sequential organ failure assessment) score and proportion of administration of inappropriate antibiotics was associated with CKD.

Conclusion: SAB bacteremia in CKD was combined with high SOFA score. Administration of inappropriate antibiotics might cause high mortality in patients with CKD.

Isenção de responsabilidade: Este resumo foi traduzido usando ferramentas de inteligência artificial e ainda não foi revisado ou verificado.